{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:17:24Z","timestamp":1793863044498,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology of Taiwan","doi-asserted-by":"crossref","award":["NSTC112-2221-E-038-006-MY3"],"award-info":[{"award-number":["NSTC112-2221-E-038-006-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology of Taiwan","doi-asserted-by":"crossref","award":["NSTC113-2628-B-038-008-MY3"],"award-info":[{"award-number":["NSTC113-2628-B-038-008-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"crossref","award":["DP3-114-62322-04"],"award-info":[{"award-number":["DP3-114-62322-04"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-026-08337-z","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:35:10Z","timestamp":1776162910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CXCL10 as a migration-associated biomarker in oral squamous cell carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Ying-Sui","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"1","key":"8337_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/prd.12542","volume":"96","author":"A Radaic","year":"2024","unstructured":"Radaic A, Kamarajan P, Cho A, Wang S, Hung GC, Najarzadegan F, et al. Biological biomarkers of oral cancer. Periodontol 2000. 2024;96(1):250\u201380.","journal-title":"Periodontol 2000"},{"issue":"5","key":"8337_CR2","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s13402-025-01068-3","volume":"48","author":"N Xue","year":"2025","unstructured":"Xue N, Wang Y, Wang Z, Zeng X, Wang J, Zhang X. Trends in immunotherapy for oral squamous cell carcinoma. Cell Oncol (Dordr). 2025;48(5):1159\u201379.","journal-title":"Cell Oncol (Dordr)"},{"key":"8337_CR3","doi-asserted-by":"crossref","unstructured":"Kujan O, van Schaijik B, Farah CS. Immune checkpoint inhibitors in oral cavity squamous cell carcinoma and oral potentially malignant disorders: a systematic review. Cancers (Basel). 2020;12(7):1937.","DOI":"10.3390\/cancers12071937"},{"key":"8337_CR4","doi-asserted-by":"publisher","first-page":"117534","DOI":"10.1016\/j.lfs.2020.117534","volume":"249","author":"K Mortezaee","year":"2020","unstructured":"Mortezaee K. CXCL12\/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis. Life Sci. 2020;249:117534.","journal-title":"Life Sci"},{"issue":"11","key":"8337_CR5","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li J, Lei W, Wang H, Ni Y, Liu Y, et al. CXCL12-CXCR4\/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications. Int J Biol Sci. 2023;19(11):3341\u201359.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"8337_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12967-025-06707-9","volume":"23","author":"H Lou","year":"2025","unstructured":"Lou H, Xia Y, Shao S, Liu X, Li Z, Yu H, et al. CXCR4\/CXCL12 axis promotes lymphatic metastasis in tongue squamous cell carcinoma via PI3K\/AKT signaling pathway. J Transl Med. 2025;23(1):757.","journal-title":"J Transl Med"},{"key":"8337_CR7","doi-asserted-by":"publisher","first-page":"107153","DOI":"10.1016\/j.intimp.2020.107153","volume":"95","author":"G Nie","year":"2021","unstructured":"Nie G, Cao X, Mao Y, Lv Z, Lv M, Wang Y, et al. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin. Int Immunopharmacol. 2021;95:107153.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"8337_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41419-023-06230-z","volume":"14","author":"R Huang","year":"2023","unstructured":"Huang R, Wang Z, Hong J, Wu J, Huang O, He J, et al. Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy. Cell Death Dis. 2023;14(10):703.","journal-title":"Cell Death Dis"},{"issue":"7","key":"8337_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura T, Li C, Wang Y, Matsukawa A. The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol. 2023;20(7):714\u201338.","journal-title":"Cell Mol Immunol"},{"key":"8337_CR10","doi-asserted-by":"publisher","first-page":"115318","DOI":"10.1016\/j.addr.2024.115318","volume":"209","author":"S Pozzi","year":"2024","unstructured":"Pozzi S, Satchi-Fainaro R. The role of CCL2\/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine. Adv Drug Deliv Rev. 2024;209:115318.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"8337_CR11","first-page":"2495","volume":"19","author":"E Nozaki","year":"2020","unstructured":"Nozaki E, Kobayashi T, Ohnishi H, Ohtsuka K, Masaki T, Watanabe T, et al. C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10. Oncol Lett. 2020;19(3):2495\u2013501.","journal-title":"Oncol Lett"},{"key":"8337_CR12","doi-asserted-by":"publisher","first-page":"100690","DOI":"10.1016\/j.jbo.2025.100690","volume":"52","author":"BB Gyau","year":"2025","unstructured":"Gyau BB, Wang J, Chen X, Clement MA, Man ZD, Major AM, et al. The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma. J Bone Oncol. 2025;52:100690.","journal-title":"J Bone Oncol"},{"issue":"1","key":"8337_CR13","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41467-020-15188-x","volume":"11","author":"M Pein","year":"2020","unstructured":"Pein M, Insua-Rodriguez J, Hongu T, Riedel A, Meier J, Wiedmann L, et al. Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs. Nat Commun. 2020;11(1):1494.","journal-title":"Nat Commun"},{"issue":"9","key":"8337_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.52586\/4969","volume":"26","author":"L Burn","year":"2021","unstructured":"Burn L, Gutowski N, Whatmore J, Giamas G, Pranjol MZI. The role of astrocytes in brain metastasis at the interface of circulating tumour cells and the blood brain barrier. Front Biosci (Landmark Ed). 2021;26(9):590\u2013601.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"8337_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12964-020-00667-x","volume":"19","author":"J Qian","year":"2021","unstructured":"Qian J, Gong ZC, Zhang YN, Wu HH, Zhao J, Wang LT, et al. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer. Cell Commun Signal. 2021;19(1):9.","journal-title":"Cell Commun Signal"},{"key":"8337_CR16","doi-asserted-by":"crossref","unstructured":"Jie X, Chen Y, Zhao Y, Yang X, Xu Y, Wang J, et al. Targeting KDM4C enhances CD8(+) T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer. J Immunother Cancer. 2022;10(2):e003716.","DOI":"10.1136\/jitc-2021-003716"},{"issue":"16","key":"8337_CR17","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1158\/0008-5472.CAN-22-3114","volume":"83","author":"C Chen","year":"2023","unstructured":"Chen C, Shin JH, Fang Z, Brennan K, Horowitz NB, Pfaff KL, et al. Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma. Cancer Res. 2023;83(16):2645\u201355.","journal-title":"Cancer Res"},{"issue":"1","key":"8337_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.21873\/cgp.20429","volume":"21","author":"L Li","year":"2024","unstructured":"Li L, Kanemitsu K, Ohnishi K, Yamada R, Yano H, Fujiwara Y, et al. CXCL10 Expression in Human Colorectal Cancer Tissue and its Correlation With Serum Levels of CXCL10. Cancer Genomics Proteom. 2024;21(1):54\u201364.","journal-title":"Cancer Genomics Proteom"},{"issue":"1","key":"8337_CR19","doi-asserted-by":"publisher","first-page":"2538962","DOI":"10.1080\/15384047.2025.2538962","volume":"26","author":"OA Madkhali","year":"2025","unstructured":"Madkhali OA, Moni SS, Almoshari Y, Sabei FY, Safhi AY. Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment. Cancer Biol Ther. 2025;26(1):2538962.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"8337_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00262-017-1975-1","volume":"66","author":"T Ohkuri","year":"2017","unstructured":"Ohkuri T, Kosaka A, Ishibashi K, Kumai T, Hirata Y, Ohara K, et al. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site. Cancer Immunol Immunother. 2017;66(6):705\u201316.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"8337_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbrc.2019.11.107","volume":"522","author":"S Harabuchi","year":"2020","unstructured":"Harabuchi S, Kosaka A, Yajima Y, Nagata M, Hayashi R, Kumai T, et al. Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma. Biochem Biophys Res Commun. 2020;522(2):408\u201314.","journal-title":"Biochem Biophys Res Commun"},{"key":"8337_CR22","doi-asserted-by":"crossref","unstructured":"Tanagala KKK, Morin-Baxter J, Carvajal R, Cheema M, Dubey S, Nakagawa H, et al. SP140 inhibits STAT1 signaling, induces IFN-gamma in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response. J Immunother Cancer. 2022;10(12):e005088.","DOI":"10.1136\/jitc-2022-005088"},{"issue":"5","key":"8337_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1158\/2326-6066.CIR-22-0317","volume":"11","author":"L Li","year":"2023","unstructured":"Li L, Hao S, Gao M, Liu J, Xu X, Huang J, et al. HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells. Cancer Immunol Res. 2023;11(5):657\u201373.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"8337_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1158\/0008-5472.CAN-23-1448","volume":"84","author":"C Li","year":"2024","unstructured":"Li C, Guo H, Zhai P, Yan M, Liu C, Wang X, et al. Spatial and Single-Cell Transcriptomics Reveal a Cancer-Associated Fibroblast Subset in HNSCC That Restricts Infiltration and Antitumor Activity of CD8\u2009+\u2009T Cells. Cancer Res. 2024;84(2):258\u201375.","journal-title":"Cancer Res"},{"issue":"2","key":"8337_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41417-023-00704-0","volume":"31","author":"J Wu","year":"2024","unstructured":"Wu J, Shen Y, Zeng G, Liang Y, Liao G. SPP1(+) TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma. Cancer Gene Ther. 2024;31(2):311\u201321.","journal-title":"Cancer Gene Ther"},{"key":"8337_CR26","doi-asserted-by":"publisher","first-page":"105925","DOI":"10.1016\/j.archoralbio.2024.105925","volume":"161","author":"VP Thakore","year":"2024","unstructured":"Thakore VP, Patel KD, Vora HH, Patel PS, Jain NK. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma. Arch Oral Biol. 2024;161:105925.","journal-title":"Arch Oral Biol"},{"issue":"8","key":"8337_CR27","doi-asserted-by":"publisher","first-page":"e0329231","DOI":"10.1371\/journal.pone.0329231","volume":"20","author":"W Gao","year":"2025","unstructured":"Gao W, Yuan H, Qing S. Bioinformatics analysis and experimental validation of the potential relationship between bacterial lipopolysaccharide and oral squamous cell carcinoma. PLoS ONE. 2025;20(8):e0329231.","journal-title":"PLoS ONE"},{"issue":"Database issue","key":"8337_CR28","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41(Database issue):D991\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"8337_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics. 2015;16(1):169.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"8337_CR30","doi-asserted-by":"publisher","first-page":"101065","DOI":"10.1016\/j.jpha.2024.101065","volume":"15","author":"O Menyhart","year":"2025","unstructured":"Menyhart O, Kothalawala WJ, Gyorffy B. A gene set enrichment analysis for cancer hallmarks. J Pharm Anal. 2025;15(5):101065.","journal-title":"J Pharm Anal"},{"issue":"8","key":"8337_CR31","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36(8):2628\u20139.","journal-title":"Bioinformatics"},{"issue":"D1","key":"8337_CR32","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"8337_CR33","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C. Pathview: an R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830\u20131.","journal-title":"Bioinformatics"},{"issue":"Database issue","key":"8337_CR34","doi-asserted-by":"publisher","first-page":"D561","DOI":"10.1093\/nar\/gkq973","volume":"39","author":"D Szklarczyk","year":"2011","unstructured":"Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39(Database issue):D561\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"8337_CR35","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"8337_CR36","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"Suppl 4","key":"8337_CR37","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"8","key":"8337_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"key":"8337_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"key":"8337_CR40","doi-asserted-by":"publisher","first-page":"570736","DOI":"10.3389\/fonc.2020.570736","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, Wu T, Gong S, Zhou H, Yu L, Liang M, et al. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma. Front Oncol. 2020;10:570736.","journal-title":"Front Oncol"},{"issue":"1","key":"8337_CR41","doi-asserted-by":"publisher","first-page":"16134","DOI":"10.1038\/s41598-021-95718-9","volume":"11","author":"I Mito","year":"2021","unstructured":"Mito I, Takahashi H, Kawabata-Iwakawa R, Ida S, Tada H, Chikamatsu K. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Sci Rep. 2021;11(1):16134.","journal-title":"Sci Rep"},{"key":"8337_CR42","doi-asserted-by":"crossref","unstructured":"Krum D, Rosch S, Warta R, Mogler C, Yilmaz Topcuoglu MS, Grabe N, et al. Spatial distribution and prognostic value of T cell subtypes and immune biomarkers in p16-negative HNSCC. Cells. 2025;14(11):789.","DOI":"10.3390\/cells14110789"},{"key":"8337_CR43","doi-asserted-by":"publisher","first-page":"104738","DOI":"10.1016\/j.critrevonc.2025.104738","volume":"211","author":"T Braun","year":"2025","unstructured":"Braun T, Bisht A, Zhu C, Idrees M, Alabeedi F, Kujan O. Diagnostic, prognostic, and metastatic value of chemokines as biomarkers for oral squamous cell carcinoma and their precursor lesions - A systematic review. Crit Rev Oncol Hematol. 2025;211:104738.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8337_CR44","doi-asserted-by":"crossref","unstructured":"Huang YC, Huang JL, Tseng LC, Yu PH, Chen SY, Lin CS. High expression of interferon pathway genes CXCL10 and STAT2 is associated with activated T-cell signature and better outcome of oral cancer patients. J Pers Med. 2022;12(2):140.","DOI":"10.3390\/jpm12020140"},{"issue":"5","key":"8337_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/jir.2023.0158","volume":"44","author":"M Sampaio","year":"2024","unstructured":"Sampaio M, Santos RVC, Albuquerque APB, Soares AKA, Cordeiro MF, da Rosa MM, et al. Induction of SK-MEL-28 Invasion by Brain Cortical Cell-Conditioned Medium Through CXCL10 Signaling. J Interferon Cytokine Res. 2024;44(5):198\u2013207.","journal-title":"J Interferon Cytokine Res"},{"key":"8337_CR46","doi-asserted-by":"publisher","first-page":"105503","DOI":"10.1016\/j.ebiom.2024.105503","volume":"111","author":"H Hu","year":"2025","unstructured":"Hu H, Li X, Xu Z, Tao Y, Zhao L, You H, et al. OPG promotes lung metastasis by reducing CXCL10 production of monocyte-derived macrophages and decreasing NK cell recruitment. EBioMedicine. 2025;111:105503.","journal-title":"EBioMedicine"},{"issue":"3","key":"8337_CR47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13(3):272\u201380.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8337_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00018-023-04715-w","volume":"80","author":"L Dillemans","year":"2023","unstructured":"Dillemans L, De Somer L, Neerinckx B, Proost P. A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment. Cell Mol Life Sci. 2023;80(3):78.","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"8337_CR49","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1158\/0008-5472.CAN-23-0193","volume":"83","author":"Z Chen","year":"2023","unstructured":"Chen Z, Zhang G, Ren X, Yao Z, Zhou Q, Ren X, et al. Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer. Cancer Res. 2023;83(21):3544\u201361.","journal-title":"Cancer Res"},{"key":"8337_CR50","doi-asserted-by":"crossref","unstructured":"Shinn CK, Saddawi-Konefka R, Salanga CL, Schokrpur S, Gutkind JS, Handel TM. Activating the CXCR3\/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma. bioRxiv. 2025:2025.04.24.650529.","DOI":"10.1101\/2025.04.24.650529"},{"issue":"2","key":"8337_CR51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, et al. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. Clin Cancer Res. 2020;26(2):487\u2013504.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8337_CR52","doi-asserted-by":"publisher","first-page":"e1515057","DOI":"10.1080\/2162402X.2018.1515057","volume":"8","author":"SH Kang","year":"2019","unstructured":"Kang SH, Keam B, Ahn YO, Park HR, Kim M, Kim TM, et al. Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma. Oncoimmunology. 2019;8(1):e1515057.","journal-title":"Oncoimmunology"},{"issue":"4","key":"8337_CR53","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ijrobp.2025.06.3856","volume":"123","author":"N Obertopp","year":"2025","unstructured":"Obertopp N, Bekker RA, Grass GD, Zelenka T, Thomas A, Potez M, et al. Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes. Int J Radiat Oncol Biol Phys. 2025;123(4):1102\u201315.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"8337_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ohn.1096","volume":"172","author":"S Maddineni","year":"2025","unstructured":"Maddineni S, Sharma K, Mohammad IA, Shin JH, Sunwoo JB. Intraepithelial ILC1-Like NK Cells Increase Lymphocyte Infiltration into the Tumor Microenvironment via the CXCL10 Axis. Otolaryngol Head Neck Surg. 2025;172(2):697\u2013701.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"8337_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.oraloncology.2019.05.019","volume":"94","author":"P Economopoulou","year":"2019","unstructured":"Economopoulou P, Koutsodontis G, Strati A, Kirodimos E, Giotakis E, Maragoudakis P, et al. Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC). Oral Oncol. 2019;94:93\u2013100.","journal-title":"Oral Oncol"},{"key":"8337_CR56","doi-asserted-by":"crossref","unstructured":"Do HTT, Lee CH, Cho J. Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers. Cancers (Basel). 2020;12(2):287.","DOI":"10.3390\/cancers12020287"},{"issue":"9","key":"8337_CR57","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s12094-020-02299-6","volume":"22","author":"J Chen","year":"2020","unstructured":"Chen J, Chen QL, Wang WH, Chen XL, Hu XQ, Liang ZQ, et al. Prognostic and predictive values of CXCL10 in colorectal cancer. Clin Transl Oncol. 2020;22(9):1548\u201364.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"8337_CR58","doi-asserted-by":"publisher","first-page":"20241117","DOI":"10.1515\/med-2024-1117","volume":"20","author":"X Wu","year":"2025","unstructured":"Wu X, Rong L, Tang R, Li Q, Wang F, Deng X, et al. Unveiling the role of CXCL10 in pancreatic cancer progression: A novel prognostic indicator. Open Med (Wars). 2025;20(1):20241117.","journal-title":"Open Med (Wars)"},{"issue":"8","key":"8337_CR59","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.ccell.2025.05.017","volume":"43","author":"F Huang","year":"2025","unstructured":"Huang F, Liu Z, Song Y, Wang G, Shi A, Chen T, et al. Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma. Cancer Cell. 2025;43(8):1460\u2013e7510.","journal-title":"Cancer Cell"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08337-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:03:08Z","timestamp":1781571788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08337-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8337"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08337-z","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study used only publicly available, de-identified datasets and commercially obtained anonymized tissue microarrays, and therefore did not require institutional review board approval or individual informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1038"}}